Cargando…
The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
Background. There are no Canadian prevalence studies on pulmonary arterial hypertension (PAH) to date. We described the characteristics of treated PAH patients and the healthcare utilization and costs associated with PAH in a population of public drug plan beneficiaries in Ontario, Canada. Methods....
Autores principales: | Vaid, Haris M., Camacho, Ximena, Granton, John T., Mamdani, Muhammad M., Yao, Zhan, Singh, Samantha, Juurlink, David N., Gomes, Tara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904539/ https://www.ncbi.nlm.nih.gov/pubmed/27445555 http://dx.doi.org/10.1155/2016/6279250 |
Ejemplares similares
-
Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
por: Antoniou, Tony, et al.
Publicado: (2015) -
Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada
por: Eibl, Joseph K., et al.
Publicado: (2015) -
Risk of incident diabetes among patients treated with statins: population based study
por: Carter, Aleesa A, et al.
Publicado: (2013) -
Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018) -
Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study
por: Kaplovitch, Eric, et al.
Publicado: (2015)